Skip to Content

Moxifloxacin Injection

Last Updated: June 6, 2018
Status: Current

Products Affected - Description
    • Avelox I.V. injection, Bayer, 400 mg/250 mL, premixed bag, 12 count, NDC 50419-0537-01
    • Moxifloxacin injection, Fresenius Kabi, 400 mg/250 mL, premixed bag, 12 count, NDC 63323-0850-74
    • Moxifloxacin injection, Mylan Institutional, 400 mg/250 mL, premixed bag, 12 count, NDC 67457-0323-25
Reason for the Shortage
    • Bayer discontinued Avelox IV in December 2017.
    • Fresenius Kabi has moxifloxacin injection on shortage due to increased demand.
    • Mylan Institutional did not provide a reason for the shortage.
Available Products
    • There are no presentations available

Estimated Resupply Dates

    • Fresenius Kabi has moxifloxacin 400 mg/250 mL premixed bags on back order and the company estimates a release date of late-June 2018.
    • Mylan Institutional has moxifloxacin 400 mg/250 mL premixed bags on back order and the company estimates a release date of early-August 2018.

Updated

Updated June 6, 2018 by Megan Dryer, PharmD. Created October 30, 2017 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide